Hankook Cosmetics Manufacturing Corporate Governance Report: Widespread Non-Compliance with Core Principles, Weak Shareholder Rights and Internal Controls
General meeting convocation notice sent only 3 weeks prior, falling short of recommended 4 weeks, limiting shareholder review time
Held AGM on concentrated dates for the past 3 years, but offered electronic voting and proxy solicitation
No formal dividend policy or mid-to-long-term shareholder return policy; no dividend predictability provided
Lack of CEO succession plan, enterprise risk management policy, and disclosure information management policy
Board chair is the CEO; only 1 outside director out of 3 (33%), limiting independence
No independent internal audit department; audit committee not established; meetings with external auditors less than quarterly
No individual evaluation or compensation policy for outside directors; no board committees
Issued 58.2 billion won in unsecured private exchangeable bonds (15th series) convertible into 4,534,965 shares, posing potential dilution
Completed stock split (500 won → 100 won) in April 2026, increasing outstanding shares to 22,660,000 for improved liquidity
Strong financial performance: consolidated revenue 184.6 billion won, operating profit 32.9 billion won, net profit 27.4 billion won
[AI Summary]This corporate governance report reveals widespread non-compliance with core principles in shareholder rights, board independence, and internal controls, potentially undermining investor confidence. While strong earnings growth and the stock split are positive, the potential dilution from exchangeable bonds and governance weaknesses pose risks to long-term shareholder value.